Roche Announces Positive Results From Phase III Study Of Crovalimab In PNH
7/2 07:59
(RTTNews) - Roche (RHHBY) announced positive results from the global phase III COMMODORE 2 study, evaluating the efficacy and safety of crovalimab in people with paroxysmal nocturnal haemoglobinuria or PNH who have not been previously treated with complement inhibitors....